Anti-IBP6/ IGFBP6 functional antibody

Anti-IBP6/ IGFBP6 functional antibody for cell culture, ELISA & in-vivo assay

Target products collectionGo to IGFBP6/IGFBP6 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-T61800-Ab-1/ GM-Tg-hg-T61800-Ab-2Anti-Human IGFBP6 monoclonal antibodyHuman
GM-Tg-rg-T61800-Ab-1/ GM-Tg-rg-T61800-Ab-2Anti-Rat IGFBP6 monoclonal antibodyRat
GM-Tg-mg-T61800-Ab-1/ GM-Tg-mg-T61800-Ab-2Anti-Mouse IGFBP6 monoclonal antibodyMouse
GM-Tg-cynog-T61800-Ab-1/ GM-Tg-cynog-T61800-Ab-2Anti-Cynomolgus/ Rhesus macaque IGFBP6 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-T61800-Ab-1/ GM-Tg-felg-T61800-Ab-2Anti-Feline IGFBP6 monoclonal antibodyFeline
GM-Tg-cang-T61800-Ab-1/ GM-Tg-cang-T61800-Ab-2Anti-Canine IGFBP6 monoclonal antibodyCanine
GM-Tg-bovg-T61800-Ab-1/ GM-Tg-bovg-T61800-Ab-2Anti-Bovine IGFBP6 monoclonal antibodyBovine
GM-Tg-equg-T61800-Ab-1/ GM-Tg-equg-T61800-Ab-2Anti-Equine IGFBP6 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-T61800-Ab-1/ GM-Tg-hg-T61800-Ab-2; GM-Tg-rg-T61800-Ab-1/ GM-Tg-rg-T61800-Ab-2;
GM-Tg-mg-T61800-Ab-1/ GM-Tg-mg-T61800-Ab-2; GM-Tg-cynog-T61800-Ab-1/ GM-Tg-cynog-T61800-Ab-2;
GM-Tg-felg-T61800-Ab-1/ GM-Tg-felg-T61800-Ab-2; GM-Tg-cang-T61800-Ab-1/ GM-Tg-cang-T61800-Ab-2;
GM-Tg-bovg-T61800-Ab-1/ GM-Tg-bovg-T61800-Ab-2; GM-Tg-equg-T61800-Ab-1/ GM-Tg-equg-T61800-Ab-2
Products NameAnti-IGFBP6 monoclonal antibody
Formatmab
Target NameIGFBP6
Protein Sub-locationSecreted Protein/Potential Cytokines
Category of antibodyFACS/Biofunctional Antibody, Therapeutics Target antibody, Cytokine antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The biofunction of antibodies are validated with in-vitro assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-IGFBP6 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation Lyophilized from sterile PBS, PH 7.4
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-T61800-Ag-1Recombinant multi-species IBP6/ IGFBP6 protein
    CytokineGM-Tg-g-T61800-Ag-1insulin-like growth factor binding protein 6 (IGFBP6) protein
    ORF Viral VectorvGMLP000789human IGFBP6 Lentivirus particle
    ORF Viral VectorpGMLP000789human IGFBP6 Lentivirus plasmid
    ORF Viral VectorpGMLPm001915mouse Igfbp6 Lentivirus plasmid
    ORF Viral VectorvGMLPm001915mouse Igfbp6 Lentivirus particle


    Target information

    Target IDGM-T61800
    Target NameIGFBP6
    Gene ID3489,16012,25641,699022,607374,101082759,404186,100034156
    Gene Symbol and SynonymsIBP6,IGF-BP6,IGFBP-6,IGFBP6,RBP6A,RBP6G
    Uniprot AccessionP24592,P35572,Q05718
    Uniprot Entry NameIBP6_HUMAN,IBP6_RAT,IBP6_BOVIN
    Protein Sub-locationSecreted Protein/Potential Cytokines
    CategoryTherapeutics Target, Cytokine Target
    DiseaseProstate Cancer, Dent disease
    Gene EnsemblENSG00000167779
    Target ClassificationN/A

    The target: IGFBP6, gene name: IGFBP6, also named as IBP6. Enables identical protein binding activity and insulin-like growth factor II binding activity. Involved in cell migration and positive regulation of stress-activated MAPK cascade. Part of insulin-like growth factor binary complex. Implicated in obesity. Biomarker of breast cancer; in situ carcinoma; leiomyoma; and neovascular inflammatory vitreoretinopathy. [provided by Alliance of Genome Resources, Apr 2022].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.